Literature DB >> 35598218

The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells.

Chong Zhang1, Huxia Gu2, Dingrong Liu3, Fuyun Tong3, Huijie Wei3, Dan Zhou3, Jing Fang3, Xiaolu Dai3, Haibo Tian3.   

Abstract

Papillary thyroid carcinoma (PTC) is a common thyroid malignancy. Circular RNAs (circRNAs) have been implicated in the development of PTC. Here, we explored the function and mechanism of circRNA family with sequence similarity 53, member B (circ_FAM53B) in PTC pathogenesis. Circ_FAM53B, microRNA (miR)-183-5p and coiled-coil domain containing 6 (CCDC6) levels were gauged by quantitative reverse transcription polymerase chain reaction (qRT-PCR) or Western blotting. The direct relationship between miR-183-5p and circ_FAM53B or CCDC6 was verified by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Our data showed that circ_FAM53B expression was reduced in PTC tissues and cells. Circ_FAM53B expression restrained proliferation, migration, and invasion and triggered apoptosis of PTC cells, as well as hindered HUVEC tube formation. Circ_FAM53B repressed miR-183-5p expression. MiR-183-5p re-expression reversed the effects of circ_FAM53B on cell behaviors. MiR-183-5p targeted and inhibited CCDC6, and circ_FAM53B upregulated CCDC6 through miR-183-5p competition. MiR-183-5p knockdown repressed cell proliferation, migration, invasion, and tube formation and facilitated apoptosis by upregulating CCDC6. Furthermore, circ_FAM53B reduced tumor growth in vivo. Collectively, our findings suggest that circ_FAM53B affects PTC cell biological behaviors via the miR-183-5p-CCDC6 axis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CCDC6; Circ_FAM53B; MiR-183-5p; Papillary thyroid carcinoma

Year:  2022        PMID: 35598218     DOI: 10.1007/s11010-022-04465-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.

Authors:  Chuankui Wei; Hongming Song; Xiaoguo Sun; Dengfeng Li; Jialu Song; Kaiyao Hua; Lin Fang
Journal:  Oncol Rep       Date:  2015-05-11       Impact factor: 3.906

Review 2.  Thyroid cancer.

Authors:  Maria E Cabanillas; David G McFadden; Cosimo Durante
Journal:  Lancet       Date:  2016-05-27       Impact factor: 79.321

3.  Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.

Authors:  Qin Liu; Liang-Zhi Pan; Min Hu; Jian-Ying Ma
Journal:  Pathol Oncol Res       Date:  2019-07-09       Impact factor: 3.201

4.  Upregulation of circular RNA circ‑FAM53B predicts adverse prognosis and accelerates the progression of ovarian cancer via the miR‑646/VAMP2 and miR‑647/MDM2 signaling pathways.

Authors:  Dan Sun; Jianing Liu; Lili Zhou
Journal:  Oncol Rep       Date:  2019-10-10       Impact factor: 3.906

Review 5.  MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.

Authors:  Agnieszka Zembska; Aleksandra Jawiarczyk-Przybyłowska; Beata Wojtczak; Marek Bolanowski
Journal:  Anticancer Res       Date:  2019-01       Impact factor: 2.480

6.  Microarray profiling of circular RNAs in human papillary thyroid carcinoma.

Authors:  Nianchun Peng; Lixin Shi; Qiao Zhang; Ying Hu; Nanpeng Wang; Hui Ye
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

7.  Profile and clinical implication of circular RNAs in human papillary thyroid carcinoma.

Authors:  Huihui Ren; Zhelong Liu; Siyue Liu; Xinrong Zhou; Hong Wang; Jinchao Xu; Daowen Wang; Gang Yuan
Journal:  PeerJ       Date:  2018-08-07       Impact factor: 2.984

Review 8.  Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.

Authors:  Mardiaty Iryani Abdullah; Sarni Mat Junit; Khoon Leong Ng; Jaime Jacqueline Jayapalan; Barani Karikalan; Onn Haji Hashim
Journal:  Int J Med Sci       Date:  2019-02-28       Impact factor: 3.738

9.  Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.

Authors:  Xiaoyan Jin; Zhengyi Wang; Wenyang Pang; Jian Zhou; Yong Liang; Jingjin Yang; Linjun Yang; Qiang Zhang
Journal:  Med Sci Monit       Date:  2018-08-07

10.  Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis.

Authors:  Yanhe Liu; Hui Li; Xiaoyi Ye; Anlong Ji; Xiangwei Fu; Haishan Wu; Xiangyong Zeng
Journal:  World J Surg Oncol       Date:  2020-09-29       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.